- Filed
- Aug 12, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 31, 2024 | 56.43M sh |
| Short Term Investments | Q2 2024 · Jun 30, 2024 | $267.49M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $71M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $16.37M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $11.55M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $20.91M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $11.55M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $357.89M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $250.94M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $367.99M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $254.67M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $175.53M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $133.96M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 28.02M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 27.98M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $5K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$23.95M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $200.4M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $211.36M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $221.22M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.45 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.85 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.45 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.85 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $6.01M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $11.47M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$12.57M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$23.75M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$11.19M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$15.1M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$28.6M |